edecesertib (GS-5718) / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
edecesertib (GS-5718) / Gilead
ACTRN12621000785808p: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Not yet recruiting
1
32
 
Gilead Sciences, Gilead Sciences
Inflammatory Diseases
 
 
ACTRN12621000785808: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Recruiting
1
32
 
Gilead Sciences, Gilead Sciences
Inflammatory Diseases
 
 
NCT04809623: Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)

Terminated
1
3
US
Edecesertib, GS-5718, Placebo, Standard of Care
Gilead Sciences
Cutaneous Lupus Erythematosus
10/22
10/22

Download Options